Dr. Rebecca Jo Hogan, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 282 Berlin Mall Rd, Unit 4, Berlin, VT 05602 Phone: 802-223-2090 Fax: 802-223-5336 |
Dr. Mark A Leipert, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 282 Berlin Mall Rd, Unit 4, Berlin, VT 05602 Phone: 802-223-2090 Fax: 802-223-5336 |
Optical Expressions Berlin Optometrist Medicare: Not Enrolled in Medicare Practice Location: 282 Berlin Mall Rd, Unit 4, Berlin, VT 05602 Phone: 802-223-2090 Fax: 802-223-5336 |
Dr. Garuna Hartnett, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 282 Berlin Mall Rd Ste 4, Berlin, VT 05602 Phone: 802-223-2090 Fax: 802-223-5336 |
News Archive
Food allergy experts from the American College of Allergy, Asthma and Immunology are available to comment as the National Institute of Allergy and Infectious Diseases releases the Guidelines for the Diagnosis and Management of Food Allergy on December 6. The ACAAI was one of more than 30 professional organizations, federal agencies and lay organizations who collaborated on the development of these recommendations.
French doctors have discovered a man who led a normal life yet his brain was considerably smaller than normal.
"A partial dose of polio vaccine was as good as a full one in providing a basic level of immunity against the crippling disease, according to a study that may offer poor countries a cheap, effective way of ensuring the disease doesn't return after it's eradicated in an area," Bloomberg reports.
Prana Biotechnology today announced that it has received approval from the Austin Health Human Research Ethics Committee (HREC) to commence a 12-month open label extension study with Alzheimer's Disease patients participating in Prana's IMAGINE trial.
Researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute report a discovery that helps scientists understand why some tumors lack immune cell infiltration and are therefore unresponsive to newer PD-1 targeted therapies.
› Verified 8 days ago